MoneyWorks4Me

USFDA completes PAI, GMP inspection at Dr. Reddy's Laboratories’ Andhra Pradesh facility

20 Jul 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) and a routine GMP inspection at Dr. Reddy's Laboratories’ API manufacturing facility in Srikakulam, Andhra Pradesh, India (CTO-6). The inspection was conducted from July 10, 2023 to July 19, 2023. The inspection closed with zero observations and a classification of No Action Indicated (NAI). 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1153.45
Cipla 1358.00
Lupin 2073.00
Zydus Lifesciences 1111.70
View more..